FISHER WALLACE LABORATORIES INC. – Trademark Portfolio
Entity Type: 03
FISHER WALLACE LABORATORIES INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FW and OAK. The owner is based in Brooklyn, NY.
630 Flushing Avenue, Suite 104
Brooklyn, NY 11206
Showing of trademarks Trademarks
Trademark Classifications
FISHER WALLACE LABORATORIES INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does FISHER WALLACE LABORATORIES INC. have?
FISHER WALLACE LABORATORIES INC. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.
What trademark classes does FISHER WALLACE LABORATORIES INC. file in?
FISHER WALLACE LABORATORIES INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are FISHER WALLACE LABORATORIES INC.'s most well-known trademarks?
FISHER WALLACE LABORATORIES INC.'s registered trademark portfolio includes well-known marks such as FW and OAK. These are among 2 currently registered trademarks in the portfolio.
What is FISHER WALLACE LABORATORIES INC.'s trademark registration success rate?
FISHER WALLACE LABORATORIES INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.